|
|
Granta Park, Great Abington,
Cambridge, CB21 6GX United Kingdom
phone:44 (1223) 896000
fax:44 (1223) 896001
|
|
| Symbol |
AZM |
| Exchange |
LON |
| Founded |
0 |
| Employees |
|
|
|
| www.alizyme.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Products to treat obesity disorders such as irritable bowel syndrome. |
|
| Management |
| Sir Brian Richards, Non-Executive Chairman; Tim McCarthy, MBA, FCCA, Chief Executive Officer; Roger Hickling, Research and Development Director; John Gordon, MA, FCA, Non-Executive Director; William Edge, Non-Executive Director
|
| |
|
|
|
|
|
|
|
| Keywords |
| metabolic, cancer, gastrointestinal, irritable, bowel, syndrome, inflammatory, bowel, disease, mucositis |
|
|
|
| Description |
|
Alizyme develops new products to treat diseases with high unmet medical need and substantial market opportunity including obesity and gastrointestinal disorders such as irritable bowel syndrome, inflammatory bowel disease and mucositis. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
